Roivios Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- (Cancelled)
- Latest Deal Amount
-
$36M
- Investors
-
1
Roivios General Information
Description
Developer of a patented technology intended to re-establish the pressure gradient necessary for kidney function. The company's lead product includes an endoscopically placed catheter set designed to deliver a mild suction (negative pressure) into the renal pelvis, enabling medical practitioners to offer treatment to simultaneously improve renal function and decrease venous congestion for fluid-overloaded patients.
Contact Information
Website
www.roivios.comCorporate Office
- Albany Financial Center
- Suite 708, South Ocean Boulevard
- Albany, New Providence
- Bahamas
Corporate Office
- Albany Financial Center
- Suite 708, South Ocean Boulevard
- Albany, New Providence
- Bahamas
Roivios Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Later Stage VC (Series A) | 29-Jul-2022 | $36M | Cancelled | Clinical Trials - General | ||
3. Later Stage VC | 01-Oct-2021 | Completed | Clinical Trials - General | |||
2. Later Stage VC | 18-Aug-2020 | $10.5M | $25M | Completed | Clinical Trials - General | |
1. Seed Round | 01-Aug-2018 | $14.5M | $14.5M | Completed | Startup |
Roivios Comparisons
Industry
Financing
Details
Roivios Competitors (4)
One of Roivios’s 4 competitors is Magenta Medical, a Venture Capital-Backed company based in Kadima, Israel.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Magenta Medical | Venture Capital-Backed | Kadima, Israel | ||||
WhiteSwell | Venture Capital-Backed | Galway, Ireland | ||||
Procyrion | Venture Capital-Backed | Houston, TX | ||||
ProKidney | Corporation | Winston-Salem, NC |
Roivios Patents
Roivios Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230364322-A1 | Wearable garment for negative pressure therapy | Pending | 10-May-2022 | ||
US-20210370019-A1 | Method of treatment using negative pressure renal therapy and medicament(s) | Pending | 28-May-2020 | ||
EP-3958918-A1 | Pump assembly and system for inducing negative pressure in a portion of a urinary tract of a patient | Pending | 23-Apr-2019 | ||
AU-2020261384-A1 | Pump assembly and system for inducing negative pressure in a portion of a urinary tract of a patient | Pending | 23-Apr-2019 | ||
CA-3138967-A1 | Pump assembly and system for inducing negative pressure in a portion of a urinary tract of a patient | Pending | 23-Apr-2019 | A61M1/82 |
Roivios Signals
Roivios Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Crown Capital (Atlanta) | PE/Buyout |
Roivios FAQs
-
When was Roivios founded?
Roivios was founded in 2015.
-
Where is Roivios headquartered?
Roivios is headquartered in Albany, Bahamas.
-
What is the size of Roivios?
Roivios has 10 total employees.
-
What industry is Roivios in?
Roivios’s primary industry is Therapeutic Devices.
-
Is Roivios a private or public company?
Roivios is a Private company.
-
What is Roivios’s current revenue?
The current revenue for Roivios is
. -
How much funding has Roivios raised over time?
Roivios has raised $31.3M.
-
Who are Roivios’s investors?
Crown Capital (Atlanta) has invested in Roivios.
-
Who are Roivios’s competitors?
Magenta Medical, WhiteSwell, Procyrion, and ProKidney are competitors of Roivios.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »